Shashikant Apte

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola et al. · New England Journal of Medicine · 2016 · 491 citations · Full text

Medicine, Hematology, Immunology +16

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Johnny Mahlangu, Jerry S. Powell, Margaret V. Ragni et al. · Blood · 2013 · 441 citations · Full text

Medicine, Hematology, Molecular Biology +14

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 352 citations · Full text

Medicine, Hematology, Immunology +14

Long‐acting recombinant factor IX Fc fusion protein (<scp>rFIXF</scp>c) for perioperative management of subjects with haemophilia B in the phase 3 <scp>B‐LONG</scp> study

Jerry S. Powell, Shashikant Apte, Hérvè Chambost et al. · British Journal of Haematology · 2014 · 49 citations · Full text

Medicine, Hematology, Perioperative Medicine +16

Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency

Cecil Ross, Mehran Karimi, Gholamreza Toogeh et al. · Journal of Thrombosis and Haemostasis · 2017 · 40 citations · Full text

Medicine, Hematology, Pharmacology +17